Construction of a Database for TTP
NCT05571774 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-10-07
Summary
Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Oct 20, 2022, to Oct 20, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical related data of thrombotic thrombocytopenic purpura.
Conditions
- TTP - Thrombotic Thrombocytopenic Purpura
Interventions
- OTHER
-
collection data
collection data
Sponsors & Collaborators
-
The First Affiliated Hospital of Soochow University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-20
- Primary Completion
- 2027-10-20
- Completion
- 2028-10-20
Countries
- China
Study Locations
More Related Trials
-
Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)
NCT01510873 ·Status: COMPLETED
-
A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
NCT02403440 ·Status: UNKNOWN ·Phase: PHASE1
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)
NCT05371743 ·Status: UNKNOWN
-
Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
NCT00251277 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment
NCT07059910 ·Status: NOT_YET_RECRUITING
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Explore the Relationship Between Platelet Count and Bleeding Score in ITP
NCT06273956 ·Status: RECRUITING
-
Herombopag + rhTPO in Severe Immune Thrombocytopenia
NCT05328804 ·Status: UNKNOWN ·Phase: PHASE3
-
to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection
NCT03664518 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909 ·Status: COMPLETED ·Phase: PHASE3
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
NCT03771378 ·Status: UNKNOWN ·Phase: PHASE4
-
Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
NCT01571349 ·Status: COMPLETED
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment
NCT01864512 ·Status: WITHDRAWN
-
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
NCT05520892 ·Status: RECRUITING ·Phase: PHASE4
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
NCT02614846 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP
NCT00571467 ·Status: TERMINATED ·Phase: PHASE1
-
Eltrombopag Phase III Study In Chinese Chronic ITP Patients
NCT01762761 ·Status: COMPLETED ·Phase: PHASE3
-
Machine-learning Based Prediction Model in Primary Immune Thrombocytopenia
NCT05116423 ·Status: UNKNOWN
-
A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
NCT04021173 ·Status: UNKNOWN ·Phase: PHASE2